Valeant Pharmaceuticals Intl Inc (TSE:VRX) (NYSE:VRX) will release its earnings data before the market opens on Tuesday, November 7th. Analysts expect Valeant Pharmaceuticals Intl to post earnings of C$1.19 per share for the quarter.

Shares of Valeant Pharmaceuticals Intl Inc (VRX) traded up 4.99% during midday trading on Tuesday, reaching $15.36. The company’s stock had a trading volume of 451,603 shares. The stock has a 50-day moving average of $16.83 and a 200 day moving average of $17.65. Valeant Pharmaceuticals Intl Inc has a 12-month low of $11.20 and a 12-month high of $32.50. The firm’s market capitalization is $5.35 billion.

A number of analysts have recently commented on the stock. Royal Bank Of Canada cut their target price on shares of Valeant Pharmaceuticals Intl to C$22.50 and set a “sector perform” rating for the company in a research note on Friday, October 20th. TD Securities increased their price target on shares of Valeant Pharmaceuticals Intl to C$26.00 and gave the company a “hold” rating in a research note on Wednesday, July 12th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of C$22.50.

In other Valeant Pharmaceuticals Intl news, Director Schutter Richard Urbain De acquired 4,900 shares of the stock in a transaction on Monday, August 21st. The shares were bought at an average cost of C$14.35 per share, with a total value of C$70,315.00. Also, Director John Paulson sold 24,700 shares of the firm’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of C$14.66, for a total transaction of C$362,102.00.

TRADEMARK VIOLATION NOTICE: This story was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/10/31/valeant-pharmaceuticals-intl-inc-vrx-to-release-earnings-on-tuesday.html.

About Valeant Pharmaceuticals Intl

Valeant Pharmaceuticals International, Inc is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices).

Receive News & Ratings for Valeant Pharmaceuticals Intl Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals Intl Inc and related companies with MarketBeat.com's FREE daily email newsletter.